Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b dose range study of propofol for minimal-to-moderate sedation during GI endoscopy
jRCT2080221299Phase 2
- Sponsor
- AstraZeneca
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial comparing Propofol arm with Intralipid placebo arm (2 arms).
02
Drugs
propofol
Beyond the preview
Go deeper on jRCT2080221299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221299.